ARWR - Cantor picks 14 undervalued biotech stocks worth a second look
2024-05-12 11:00:00 ET
More on Acadia Pharma, BridgeBio Pharma, etc.
- ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
- ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
- Rocket Pharmaceuticals: Cautiously Optimistic (Rating Upgrade)
- Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M
- Acadia Pharma Q1 2024 Earnings Preview